Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting Non-phase study NCT07436117

Evaluating the Impact AI Avatar-led Mental Health Interventions for Keeping Employees in Work

Evaluating the Impact AI Avatar-led Mental Health Interventions for Keeping Employees in Work — Recruiting • Non-phase study • Gastroenterology • NCT07436117.

📅 25 Mar 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07436117
Sponsor
University of Roehampton
Start
2025-10-07
ClinicaliQ Trial Snapshot
  • Evaluating the Impact AI Avatar-led Mental Health Interventions for Keeping Employees in Work — Recruiting • Non-phase study • Gastroenterology • NCT07436117.
  • This study will examine whether an artificial intelligence (AI) avatar-led mental health programme can help employees experiencing symptoms of depression. The programme delivers structured, self-guided psychological support over several short sessions that participants complete online over a period of several weeks. Approximately….
  • Sponsor: University of Roehampton.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study will examine whether an artificial intelligence (AI) avatar-led mental health programme can help employees experiencing symptoms of depression. The programme delivers structured, self-guided psychological support over several short sessions that participants complete online over a period of several weeks. Approximately 50-80 adults will take part. Participants will be randomly assigned either to start the AI programme immediately or to continue with their usual support and access the programme later. All participants will complete questionnaires before and after the study period to assess changes in mood, anxiety, and work…

Eligibility Snapshot
  • : * Participants will be eligible if they currently experience symptoms of depression (score above 5 on the PHQ-9) * Participants should be aged 18 or above. * Participants need to be resident in the UK.

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
How to check whether you have bowel cancer
Gastroenterology · BBC Health · 12 Feb 2026
What are the main symptoms and causes of bowel cancer, and how can you reduce your risk of getting it? This update…
View brief →
Clinical Brief
‘I used delivery apps to hide the shame of alcoholism’
Gastroenterology · BBC Health · 24 Apr 2026
Alcohol addiction can be masked through anonymous delivery services, making problematic drinking less visible to family, friends, and healthcare providers—a barrier to…
View brief →
Guideline
Cirrhosis in Over 16s: Assessment and Management (NICE NG50)
Gastroenterology · 27 Mar 2026
Perform upper endoscopy to screen all cirrhosis patients for oesophageal varices; if present, offer variceal band ligation and initiate non-selective beta-blockers (propranolol…
View guideline →
Guideline
Coeliac Disease: Recognition, Assessment and Management (NICE NG20)
Gastroenterology · 27 Mar 2026
Test for coeliac disease using tissue transglutaminase (tTG) IgA antibodies as first-line serology, with concurrent total IgA measurement; if IgA deficient, use…
View guideline →
Guideline
Irritable Bowel Syndrome in Adults: Diagnosis and Management (NICE CG61)
Gastroenterology · 27 Mar 2026
Offer structured dietary and lifestyle advice as first-line treatment, including consideration of a low FODMAP diet if standard measures are insufficient, before…
View guideline →
Clinical Brief
Prince William praises £20m milestone for Bowelbabe fund
Gastroenterology · BBC Health · 02 Apr 2026
The Bowelbabe fund, established by Dame Deborah James in 2022, has reached a £20 million fundraising milestone to support Cancer Research UK's…
View brief →